Lei Chen, Petar Jelinic, Elizabeth A. Szamreta, Sneha Sura, Gregory Patton, Feng Wang, John Murphy, Audrey Garrett. "A US real-world study of second-line outcomes in advanced ovarian cancer by first-line PARP inhibitor maintenance exposure.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e17564